UPDATE: Genmab A/S (GMAB) PT Raised to $35 at RBC Capital; 'Vast Potential for Epcoritamab'
Tweet Send to a Friend
(Updated - June 19, 2020 8:13 AM EDT)
(updated to add analyst comment)RBC Capital analyst Kennen Mackay raised the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comment)RBC Capital analyst Kennen Mackay raised the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
